Prof Fairen-Jimenez, CSO of Vector Bioscience Cambridge and Professor of Molecular Engineering at the University of Cambridge ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

Prescient investors who participated in Immaterial’s £13.5million Series A2 funding round will be delighted that the advanced ...

Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

The manuscript concerns a fundamental and controversial question in Trypanosoma brucei biology and the parasite life cycle, providing further evidence that slender bloodstream forms can indeed infect ...

AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Conexiant is proud to introduce MDspire, an AI-powered discovery and engagement platform transforming how physicians, researchers, and healthcare professionals consume clinical knowledge. Designed to ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...